Trials / Completed
CompletedNCT03306667
Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency)
Clinical Pharmacology Study of FYU-981 for Subjects With Hepatic Insufficiency
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Mochida Pharmaceutical Company, Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the pharmacokinetics, pharmacodynamics and safety after single oral administration of FYU-981 to subjects with hepatic insufficiency and with normal hepatic function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FYU-981 | Oral single dosing |
Timeline
- Start date
- 2017-10-06
- Primary completion
- 2018-06-20
- Completion
- 2018-06-25
- First posted
- 2017-10-11
- Last updated
- 2018-09-24
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03306667. Inclusion in this directory is not an endorsement.